IA
MED icon

IndexIQ Advisors’s Medifast MED Stock Holding History

IndexIQ Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$33K Sell
193
-1,965
-91% -$370K ﹤0.01% 1179
2021
Q4 		$452K Sell
2,158
-120
-5% -$24.8K 0.02% 659
2021
Q3 		$439K Buy
2,278
+267
+13% +$65.6K 0.01% 699
2021
Q2 		$569K Buy
2,011
+132
+7% +$35.8K 0.02% 407
2021
Q1 		$398K Sell
1,879
-1,472
-44% -$352K 0.01% 764
2020
Q4 		$658K Buy
3,351
+346
+12% +$61.1K 0.02% 299
2020
Q3 		$494K Buy
3,005
+162
+6% +$26.7K 0.02% 277
2020
Q2 		$395K Sell
2,843
-83
-3% -$7.62K 0.02% 269
2020
Q1 		$183K Buy
+2,926
New +$266K 0.01% 611

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

IndexIQ Advisors's MED Position: Q1 2022 in Review

IndexIQ Advisors reduced its Medifast (MED) stake by 91% in Q1 2022, selling an estimated $370K and leaving 193 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

IndexIQ Advisors first reported a position in MED in Q1 2020 and has held it in 9 quarters since. The position peaked at $658K in Q4 2020. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • IndexIQ Advisors held 193 shares of Medifast worth $33K as of Q1 2022.
  • IndexIQ Advisors sold 1,965 Medifast shares in Q1 2022, an estimated $370K.
  • Medifast made up ﹤0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1179 holding.
  • IndexIQ Advisors first reported a position in Medifast in Q1 2020 and has held it in 9 quarters since.
  • IndexIQ Advisors's Medifast position peaked at $658K in Q4 2020.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.